The effects of intrathecal neostigmine added to bupivacaine on postoperative analgesic requirement in Patients undergoing lower limb orthopaedic surgery

Trial Profile

The effects of intrathecal neostigmine added to bupivacaine on postoperative analgesic requirement in Patients undergoing lower limb orthopaedic surgery

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 26 Aug 2016

At a glance

  • Drugs Neostigmine (Primary) ; Bupivacaine
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 26 Aug 2016 Planned End Date changed from 23 Oct 2013 to NULL.
    • 17 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top